(Q48344925)

10 February 2018

review article

1 reference

title

Tiagabine: a novel antiepileptic drug. (English)

1 reference

10 February 2018

author name string

M S Luer

series ordinal

1

1 reference

10 February 2018

D H Rhoney

series ordinal

2

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

Annals of Pharmacotherapy

published in

1 reference

10 February 2018

volume

32

1 reference

10 February 2018

issue

11

1 reference

10 February 2018

page(s)

1173-1180

1 reference

10 February 2018

Newly treated childhood epilepsy: a prospective study of recurrences and side effects

cites work

1 reference

Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration

21 January 2018

1 reference

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier

21 January 2018

1 reference

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

21 January 2018

1 reference

Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.

21 January 2018

1 reference

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

21 January 2018

1 reference

A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

21 January 2018

1 reference

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

21 January 2018

1 reference

International experience with tiagabine add-on therapy.

21 January 2018

1 reference

Neuropsychological effects of tiagabine, a potential new antiepileptic drug.

21 January 2018

1 reference

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

21 January 2018

1 reference

New antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

Tiagabine pharmacology in profile

21 January 2018

1 reference

Early treatment and prognosis of epilepsy

21 January 2018

1 reference

The prognosis for seizure control in newly diagnosed epilepsy

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

1 reference

Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses

21 January 2018

1 reference

Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function

21 January 2018

1 reference

Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs

21 January 2018

1 reference

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

21 January 2018

1 reference

Tiagabine monotherapy in the treatment of partial epilepsy

21 January 2018

1 reference

Tiagabine and non-convulsive status epilepticus

21 January 2018

1 reference

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18053

1 reference

10 February 2018

PubMed ID

9825084

1 reference

10 February 2018